Philanthropists back ventilator project led by Queen's Nobel Laureate
May 1, 2020
Philanthropists from across the country are rallying to support a team of Canadian physicists and engineers who are part of an international initiative to create an easy-to-build ventilator that can help treat COVID-19 patients.
These efforts, led in Canada by Arthur B. McDonald, an emeritus professor at Queen’s University and the co-recipient of the 2015 Nobel Prize in Physics, are harnessing the talents of physicists who would normally be spending their time trying to solve the mysteries of dark matter. Since both tasks depend on the precise regulation of gas flow, Dr. McDonald and the project founder, Dr. Cristiano Galbiati in Italy, felt their fellow astroparticle physicists were perfectly positioned to help build up the world’s ventilator supply. In Canada, Dr. McDonald got instant and continuing participation from the lab directors and teams at TRIUMF Laboratory, Canadian Nuclear Laboratories at Chalk River, SNOLAB, and the McDonald Institute.
The collaboration, now called the MVM Ventilator project, has gained national attention — including a strong statement of support from Canada’s Prime Minister, Justin Trudeau, and from federal innovation, supply, and regulatory agencies.
This work at such a difficult time for the world has captured the imagination of a dozen Canadian philanthropists who have stepped forward to support the project financially with donations through Queen’s University to the Dr. Art McDonald Ventilator Research Fund.
Pictou, Nova Scotia-based Donald Sobey, a Queen’s alumnus and the chair emeritus of Empire Company Limited, was one of the first philanthropists to support the initiative, making his donation less than 24 hours after receiving an early Easter morning call from fellow Nova Scotian Dr. McDonald.
“Dr. McDonald’s leadership and brilliance in developing a Canadian solution to the global ventilator shortage during the COVID-19 pandemic is inspiring,” says Sobey. “He is one of the leading scientific minds in the world, and a source of pride for all Canadians. But when we spoke on Easter morning about the urgent issues facing his project, I was compelled by the voice of a true humanitarian.”
Other Canadian philanthropists share Sobey’s enthusiasm for the project. Supporters of now include the Lazaridis Family Foundation, The Garrett Family Foundation, Josh Felker, Dan Robichaud, Patricia Saputo, Peter Nicholson, Salvatore Guerrera, and Nicola Tedeschi, as well as four anonymous donors.
Dr. McDonald extends his thanks for this valuable support.
“The very generous donations by Donald Sobey and the other philanthropists have been crucial for us to maintain our research at a very critical time in the project," he says. "I have been amazed and extremely grateful for their very timely support, as it has enabled our team to push past obstacles towards our goal of producing large numbers of cost-effective ventilators with strong capability for saving lives.”
The MVM Ventilator project is proceeding well toward its goal through successful testing of the ventilator in Italy, Canada, and the US for certification, guided by medical experts. The collaboration team is working with manufacturers who are capable of production at rates up to 1000 per week in the near future. In Canada, the production companies will be Vexos in Markham, Ontario and JMP Solutions in London, Ontario. The development work is published openly and is being carried out with an open source licensing concept, enabling companies around the world to manufacture this design to help with shortages in other countries.
“We are thrilled that so many Canadian philanthropists have been inspired to contribute to the ventilator project,” says Karen Bertrand, Queen’s Vice-Principal (Advancement). “Their generosity is ensuring that more ventilators get in the hands of health-care professionals, and more people receive the treatment they need. This is a graphic illustration of the impact that both research and philanthropy can have on our world.”
For more information, visit the Queen’s research website.